Verition Fund Management LLC acquired a new position in shares of Semler Scientific, Inc. (NASDAQ:SMLR - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 10,645 shares of the company's stock, valued at approximately $251,000. Verition Fund Management LLC owned about 0.15% of Semler Scientific at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Principal Financial Group Inc. acquired a new stake in Semler Scientific during the third quarter worth about $361,000. Shariaportfolio Inc. acquired a new stake in Semler Scientific during the third quarter worth about $3,618,000. CWM LLC increased its position in Semler Scientific by 486.3% during the second quarter. CWM LLC now owns 897 shares of the company's stock worth $31,000 after purchasing an additional 744 shares during the last quarter. Cerity Partners LLC boosted its stake in Semler Scientific by 91.5% during the third quarter. Cerity Partners LLC now owns 1,345,586 shares of the company's stock worth $31,689,000 after buying an additional 642,982 shares during the period. Finally, Dimensional Fund Advisors LP boosted its stake in Semler Scientific by 18.3% during the second quarter. Dimensional Fund Advisors LP now owns 126,177 shares of the company's stock worth $4,341,000 after buying an additional 19,552 shares during the period. 49.37% of the stock is currently owned by institutional investors and hedge funds.
Semler Scientific Price Performance
Shares of NASDAQ SMLR traded down $4.67 during midday trading on Friday, hitting $67.17. The company's stock had a trading volume of 971,401 shares, compared to its average volume of 1,077,116. The business's fifty day simple moving average is $43.82 and its two-hundred day simple moving average is $34.79. Semler Scientific, Inc. has a 1 year low of $20.88 and a 1 year high of $79.45. The firm has a market capitalization of $556.84 million, a price-to-earnings ratio of 32.77 and a beta of 1.18.
Semler Scientific (NASDAQ:SMLR - Get Free Report) last posted its quarterly earnings data on Monday, November 4th. The company reported $0.72 EPS for the quarter, beating the consensus estimate of $0.37 by $0.35. Semler Scientific had a net margin of 27.00% and a return on equity of 20.31%. The business had revenue of $13.51 million during the quarter.
Semler Scientific Profile
(
Free Report)
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Featured Stories
Before you consider Semler Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.
While Semler Scientific currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
